Publish Time: 2025-12-12 Origin: Bioteke
In recent years, global drug abuse patterns have become increasingly complex. Traditional substances such as heroin, cocaine, and methamphetamine remain prevalent, while synthetic drugs and novel psychoactive substances (NPS) continue to emerge at a rapid pace. Their evolving chemical structures make detection more challenging and create new risks for public health, workplace safety, and social stability.
As drug use becomes more concealed — facilitated by entertainment venues, digital transactions, and cross-border circulation — governments, institutions, and healthcare providers face escalating pressure to identify substance abuse quickly and accurately. This has led to a rising demand for high-sensitivity, multi-indicator drug screening tools that can adapt to different environments and regulatory requirements.
Law enforcement & judiciary rely on rapid toxicology screening for roadside inspections, customs monitoring, anti-drug enforcement, and rehabilitation tracking.
Healthcare facilities, especially emergency departments, need immediate toxicology results to triage acute poisoning cases and initiate timely medical interventions.
Schools and educational institutions use drug testing to protect student safety and prevent early exposure to harmful substances.
Companies and workplaces implement routine testing to ensure safer working environments, especially in transportation, logistics, and industrial operations.
Beyond operational needs, drug testing carries broader social value: it reduces crime, supports early intervention, assists rehabilitation, and protects vulnerable populations. A strong drug-screening infrastructure is essential for maintaining public safety and building healthier communities.
As the demand for fast, accurate, and customizable screening solutions continues to rise, Bioteke introduces a next-generation Multi-Drug Urine Test designed to meet these challenges across global markets.
Drug abuse screening has become an essential tool across law enforcement, workplace safety, public health, and clinical emergency settings. To meet the demand for fast, accurate, and user-friendly testing solutions, Bioteke has launched the Multi-Drug Urine Test, available in both panel and cup formats.
Designed with high sensitivity, flexible cut-off levels, and customizable 2–14 drug combinations, this rapid test offers a dependable solution for modern drug detection needs.
The Bioteke Multi-Drug Urine Test is a lateral-flow immunoassay used to detect multiple commonly abused drugs in human urine samples. By integrating high-performance antibodies and optimized cut-off thresholds, the test provides clear, reliable, and rapid results, supporting on-site decision-making in time-critical environments.
Bioteke offers two practical formats to meet different testing conditions:
Multi-drug test panel – simple dip-and-read design
Multi-drug test cup – all-in-one collection and testing, reducing contamination risk
Both formats support rapid screening and are ideal for both professional and non-medical operators.
The test can screen for any combination of commonly abused drugs, including:
FENT(Fentanyl)
THC(Marijuana)
MDMA(Methylenedioxymethamphetamine)
MOP(Morphine)
BZO(Benzodiazepines)
MTD(Methadone)
BAR(Barbiturates)
BUP(Buprenorphine)
OXY(Oxycodone)
AMP(Amphetamine)
COC(Cocaine)
MET(Methamphetamine)
PCP(Phenylcyclohexyl piperidine)
TCA(Nortriptyline)
With up to 14 analytes available, Bioteke’s test meets a wide range of regulatory and operational requirements.
Every industry has different screening requirements.
To support regulatory diversity across global markets, Bioteke allows customers to freely select 2 to 14 drugs based on their exact program needs.
This OEM/ODM flexibility makes the Bioteke Multi-Drug Urine Test particularly valuable for:
distributors
government agencies
clinical institutions
workplace health programs
rehabilitation facilities
The test is designed with excellent analytical sensitivity, ensuring:
accurate identification of target drug & metabolites
reduced false negatives
consistent and stable performance
The cut-off levels align with widely recognized international standards, making it suitable for compliance-driven testing programs.
The test supports fast on-site screening across:
On-site screening by public security authorities
customs and border control
roadside drug-driving inspection
nightclub or entertainment venue monitoring
drug rehabilitation
Quick results allow officers to make informed decisions immediately.
Bioteke’s Multi-Drug Urine Test is also widely applicable to:
Hospital acute poisoning screening
school health screening
workplace pre-employment testing
corporate and institutional health programs
Its reliability and ease of use make it a valuable tool in high-throughput environments.
With over 20 years of experience in the diagnostics industry, Bioteke follows strict quality standards, including ISO13485, ensuring consistent performance and supply stability.
We also provide comprehensive custom OEM/ODM services, enabling:
private labeling
custom drug combinations
tailored packaging
market-specific product configurations
The Bioteke Multi-Drug Urine Test delivers a powerful combination of accuracy, flexibility, and ease of use. Whether used in law enforcement, hospitals, schools, workplaces, or public health programs, it provides fast and dependable results when they matter most.
For distributors, importers, and healthcare partners seeking a high-quality and customizable drug screening solution, Bioteke offers a complete, scalable platform tailored to global market needs.
The test covers up to 14 commonly abused drugs, including FENT, AMP, MET, MDMA, COC, THC, MTD, BZO, BAR, and more. Panels(Single drug test or multi-drug test) can be fully customized.
Yes. Bioteke supports complete OEM/ODM customization. You may choose any 2 to 14 analytes based on our listed substance & your regulatory needs or market requirements.
The panel is a dip-type screening panel, while the cup integrates sample collection and testing for contamination-free workflow. Both provide fast results.
The test is designed with high sensitivity, following internationally recognized cut-off levels, ensuring consistent and reliable detection.
It is suitable for law enforcement, customs inspection, roadside drug-driving screening, rehabilitation monitoring, hospital emergency toxicology, school health testing, and workplace safety checks.
Yes. We support private labeling, customized panel combinations, packaging design, and other OEM/ODM requirements.
Results are typically available within 3–5 minutes, depending on the specific panel.
The test applies lateral flow immunoassay technology.
Drug metabolites in the urine sample bind to specific antibodies on the test membrane.
If the target drug is present above the cut-off level, the test line will not appear (competitive binding).
Clear control lines ensure that the test is functioning properly.
Collect urine sample in a clean container.
Dip the test panel into the sample for 10–15 seconds.
Place it on a flat surface and wait 3–5 minutes.
Read the results according to the instructions (C line must be present).
Collect urine directly into the cup.
Close the lid securely.
Peel off the label to expose the test strips.
Wait 3–5 minutes and read results.
Do not interpret results after the recommended reading time.
| Substance Tested | Cut-Off Level | Min Detection Time | Max Detection Time |
| THC | 50 ng/ml | 2 hours | up to 5 days |
| MDMA | 500 ng/ml | 2-7 hours | 2-4 days |
| MOP | 300 ng/ml | 2 hours | 2-3 days |
| BZO | 300 ng/ml | 2-7 hours | 1-2 days |
| MTD | 300 ng/ml | 3-8 hours | 1-3 days |
| BAR | 300 ng/ml | 2-4 hours | 1-4 days |
| BUP | 10 ng/ml | 1 hour | 1-7 days |
| OXY | 100 ng/ml | 2 hours | 2 days |
| AMP | 500 ng/ml | 2-7 hours | 1-2 days |
| COC | 150 ng/ml | 1-4 hours | 2-4 days |
| MET | 500 ng/ml | 2-7 hours | 2-4 days |
| PCP | 25 ng/ml | 4-6 hours | 1-4 days |
| TCA | 1000 ng/ml | 2 hour | 7-10 days |